KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
Original version
https://doi.org/10.1002/cncr.28979Publisher
WileyJournal
CancerCopyright
Copyright 2014 The Authors
Except where otherwise noted, this item's license is described as Attribution CC BY-NC-ND